Impact of Daylight on Patients With Acute Myocardial Infarction
Coronary Arteriosclerosis, Myocardial Infarction
About this trial
This is an interventional treatment trial for Coronary Arteriosclerosis
Eligibility Criteria
Inclusion Criteria:
- Patients with an acute myocardial infarction
- Healthy volunteers
- Must speak and understand English
Exclusion Criteria:
- Patients with an acute myocardial infarction but are too sick, e.g. severe symptoms, chest pain, generally unstable, etc.
Sites / Locations
- University of Colorado Denver | Anschutz Medical Campus
Arms of the Study
Arm 1
Arm 2
Experimental
Sham Comparator
Exposed to Day light
Exposed to Room light
Patients with myocardial infarction (MI): This group will be enrolled on the day of their MI. A blood draw will be performed before any light therapy. The patients will then receive a light box (Square One Wake Up Light NatureBright 10,000 LUX) that they shall use every morning from 8.30-9.00 AM for the next 2 weeks. At the conclusion of the two weeks another blood sample will be drawn.
Patients with myocardial infarction (MI): This group will be enrolled on the day of their MI and will only be exposed to room light. They will have blood drawn on the day of enrollment and then at 2 weeks after the MI.